New Matter: Inside the Minds of SLAS Scientists

A Critical Platform


Listen Later

Send us a text

Join Ross Lagoy  and Marshall discussing CRISPR/Cas9 genome editing, developing critical platform technologies that accelerate drug discovery and how to connect the bench to automation. Ross is a Senior Scientist at Intellia Therapeutics working to establishing new technologies and analysis pipelines to help identify potential cures for patients living with genetic disease.

Upcoming SLAS Events:

SLAS Europe 2025 Conference and Exhibition

  • 20-22 May 2025
  • Hamburg, Germany

View the full events calendar

...more
View all episodesView all episodes
Download on the App Store

New Matter: Inside the Minds of SLAS ScientistsBy SLAS